Grove Biopharma
Grove Biopharma is a biotechnology company developing novel therapies using its Bionic Biologics™ platform, which targets previously intractable intracellular disease targets. This platform integrates biologic and synthetic design principles to create cell-penetrant molecules that inhibit or degrade challenging intracellular targets. The company's initial focus is on oncology and neurodegenerative diseases.
Funding Round: Series A
Funding Amount: $30M
Date: 23-Apr-2025
Investors: DCVC Bio, Eli Lilly and Company, InVivium Capital, Walder Ventures, Gradiant Corporation, Mansueto Investments, Portal Innovations
Markets: Biotechnology, Oncology, Neurodegenerative Diseases
HQ: Chicago, Illinois, United States
Founded: 2020
Website: https://grovebiopharma.com/
LinkedIn: https://www.linkedin.com/company/grove-biopharma-inc
Crunchbase: https://www.crunchbase.com/organization/grove-biopharma
Leave a Comment
Comments
No comments yet.